Drug Profile
10-epi-11-Deoxyoxaunomycin
Latest Information Update: 21 Oct 1997
Price :
$50
*
At a glance
- Originator Mercian; Nonindustrial source
- Class Cytostatic antibiotics
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Oct 1997 No-Development-Reported for Cancer in Japan (Unknown route)
- 17 Sep 1996 New profile
- 17 Sep 1996 Preclinical development for Cancer in Japan (Unknown route)